Coronary Artery Bypass Clinical Trial
— REQUESTOfficial title:
Registry for Quality Assessment With Ultrasound Imaging and TTFM in Cardiac Bypass Surgery
NCT number | NCT02385344 |
Other study ID # | 1501 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | April 2015 |
Est. completion date | December 2017 |
Verified date | September 2018 |
Source | Medistim ASA |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational [Patient Registry] |
The purpose of the registry is to collect information regarding the number and type of coronary artery bypass (CAB) surgical procedure changes that are made based on intraoperative guidance information using transit time flow measurements (TTFM) and ultrasound image capabilities provided with the Medistim device.
Status | Completed |
Enrollment | 1046 |
Est. completion date | December 2017 |
Est. primary completion date | December 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility |
Inclusion Criteria: - Subject has been scheduled for coronary bypass surgery - Subject understands the nature of the procedure and has signed the subject informed consent prior to the procedure - Subject has been diagnosed with 2-3 vessel disease Exclusion Criteria: - Subject is scheduled for other surgical procedures during the bypass surgery (valve replacement/repair, carotid endarterectomy, etc.) - Subject is known to be suffering from any psychological, developmental, physical, or emotional disorder that the investigator feels would interfere with surgery or follow-up testing - Subject is undergoing an emergency cardiac bypass surgery - Subject has history or presence of muscle disease (i.e. myopathy, myalgia, myasthenia, rhabdomyolysis) with or without concomitant CK-elevation > 5 ULN that cannot be ascribed to any other medical condition (e.g. myocardial infarction) - Subject has any condition that the investigator believes should exclude him/her from this registry |
Country | Name | City | State |
---|---|---|---|
Canada | University of Calgary | Calgary | Alberta |
Germany | University of Duisburg-Essen, Dept. of Cardiothoracic Surgery | Essen | |
Italy | Clinica Cardiochirurgica | Chieti | |
Netherlands | Erasmus University Medical Center | Rotterdam | |
United Kingdom | University of Oxford | Oxford | |
United States | Mount Sinai Beth Israel | New York | New York |
United States | Veterans Affairs Medical Center | Washington DC | Maryland |
Lead Sponsor | Collaborator |
---|---|
Medistim ASA |
United States, Canada, Germany, Italy, Netherlands, United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in planned surgical procedure | Identify how often epiaortic scanning With the Medistim Device, leads to a change in the planned surgical procedure and to identify the reason and the procedure change | Day 1 (During Surgery) | |
Primary | Procedure adaptions | Identify the procedure adaptions made by a surgeon when TTFM and/or Medistim ultrasound imaging identify suboptimal graft function | Day 1 (During surgery) | |
Secondary | Record number of revisions | Record how many Cardiac bypass patients experience intraoperative graft revision, the type of revision, and the key identifier motivating the revision | Day 1 (During surgery) | |
Secondary | Record number of events | Record post-surgical major adverse cardiac and cerebral events (MACCE) of all bypass procedure patients entered into the registry and occuring prior to discharge | Day 1-14 (During hospitalization) | |
Secondary | Incidence rate | To determine the incidence rate of Serious Adverse Events (SAE) and/or Unanticipated Adverse Events (UAE) throughout the registry | 2 years (Throughout the study) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03235323 -
Efficacy of External CounterPulsation for Postoperative Coronary Artery Bypass Grafting Patients
|
N/A | |
Completed |
NCT05036044 -
Stroke and Carotid-Cerebral Vascular Disease After CABG
|
||
Recruiting |
NCT05010460 -
Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting
|
Phase 2 | |
Completed |
NCT03622671 -
Fibrin Clot Properties and Blood Loss Following Coronary Artery By-pass Grafting
|
N/A | |
Completed |
NCT00400790 -
Organ Protection for Coronary Artery Bypass Graft (CABG): Propofol Versus Desflurane
|
N/A | |
Not yet recruiting |
NCT03275220 -
Assessment Of Right Ventricular Function In Patients Undergoing Coronary Artery Bypass Graft In Assiut University
|
N/A | |
Completed |
NCT01256372 -
An Trial of Two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery
|
Phase 2 | |
Completed |
NCT00489827 -
Glutamate for Metabolic Intervention in Coronary Surgery
|
Phase 3 | |
Completed |
NCT04591119 -
Transversus Thoracis Muscle Plane Block for Postoperative Pain in Adult Cardiac Surgery
|
N/A | |
Active, not recruiting |
NCT03908593 -
Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABG
|
Phase 4 | |
Recruiting |
NCT03774342 -
The Influence of Cognitive Decline on Quality of Life After Coronary Bypass
|
||
Enrolling by invitation |
NCT03999398 -
Short and Long-term Results of PCI in no Touch Vein-graft.
|
||
Recruiting |
NCT05414331 -
WithDRawal Impact Of Postoperative Beta-Blocker
|
N/A | |
Completed |
NCT02981680 -
Effect of Remote Ischemic Preconditioning on the Incidence of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery
|
N/A | |
Completed |
NCT00600704 -
Impact of Fluid Restriction Policy in Reducing the Use of Red Cells in Cardiac Surgery
|
N/A | |
Completed |
NCT06013605 -
Effect of Walking Exercise on Functional Capacity and Productivity in Patients After Coronary Artery Bypass Graft
|
N/A | |
Active, not recruiting |
NCT02731794 -
On-pump Beating Coronary Artery Bypass Grafting by Ventricular Assist
|
Phase 4 | |
Completed |
NCT02722213 -
Mindfulness & Stress Management Study for Cardiac Patients
|
N/A | |
Completed |
NCT01285271 -
A Pre- and Post- Coronary Artery Bypass Graft Implantation Disposed Application of Xenon
|
Phase 3 | |
Completed |
NCT00823082 -
Use of Antithrombin in Cardiac Surgery With Cardiopulmonary Bypass
|
Phase 2 |